haMSter: a Novel Smartphone Communication Tool for People With MS

haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone.

Endpoints include the adherence to this app and satisfaction with this Intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

m-Health Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Multiple Sclerosis Nervous System Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of Vienna

Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any MS according to MacDonald criteria
informed consent

Exclusion criteria

language barriers

Treatment and study plan

haMSter smartphone app

Device

the app tracks patient reported outcomes

Primary outcomes

adherence to device

Time frame: over the course of this study (over 6 months)

Percentage (Number) of participants having completed all necessary questionnaires per study period. Max: 6 completions.

Secondary outcomes

Overall satisfaction with this application in telemedicine

Time frame: after study completion (after 6 months)

TMPQ (Telemedicine Perception Questionnaire). Min: 0 points. Max: 80 Points. Higher scores indicate a better outcome
General satisfaction with specific Features of the haMSter app

Time frame: after study completion (after 6 months)

Empirical questionnaires. We will Report frequencies of answers given. There is no Overall score in a larger sense.

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Sep 21, 2020
Registry last updated: Oct 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting